Literature DB >> 264687

Beta-endorphin: stimulation of growth hormone release in vivo.

A Dupont, L Cusan, M Garon, F Labrie, C H Li.   

Abstract

Two micrograms of beta-endorphin (beta-lipotropin61-91) injected intraventricularly in rats that had been treated with antiserum against somatostatin led to a 6- and 10-fold stimulation of the concentration of plasma growth hormone (somatotropin) measured 10 and 20 min after injection of the peptide, whereas 400 mug of methionine-enkephalin led to a 4- to 6-fold increase of levels of plasma growth hormone at 10 min with a rapid return to basal levels at later time intervals. At doses of 5 and 25 mug, beta-endorphin led to a 20- to 30-fold stimulation of levels of plasma growth hormone, the maximal effect being measured between 20 and 30 min after injection. These data suggest the possible role of the endogenous opiate-like peptides in the control of growth hormone secretion.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 264687      PMCID: PMC393259          DOI: 10.1073/pnas.74.1.358

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  17 in total

1.  Opioid activity of a peptide, beta-lipotropin-(61-91), derived from beta-lipotropin.

Authors:  B M Cox; A Goldstein; C H Hi
Journal:  Proc Natl Acad Sci U S A       Date:  1976-06       Impact factor: 11.205

2.  Isolation and structure of an untriakontapeptide with opiate activity from camel pituitary glands.

Authors:  C H Li; D Chung
Journal:  Proc Natl Acad Sci U S A       Date:  1976-04       Impact factor: 11.205

3.  C fragment of lipotropin has a high affinity for brain opiate receptors.

Authors:  N J Birdsall; E C Hulme
Journal:  Nature       Date:  1976-04-29       Impact factor: 49.962

4.  The synthesis and opiate activity of beta-endorphin.

Authors:  C H Li; S Lemaire; D Yamashiro; B A Doneen
Journal:  Biochem Biophys Res Commun       Date:  1976-07-12       Impact factor: 3.575

5.  Physiological role of somatostatin in the control of growth hormone and thyrotropin secretion.

Authors:  L Ferland; F Labrie; M Jobin; A Arimura; A V Schally
Journal:  Biochem Biophys Res Commun       Date:  1976-01-12       Impact factor: 3.575

6.  Beta-Endorphin as a potent analgesic by intravenous injection.

Authors:  L F Tseng; H H Loh; C H Li
Journal:  Nature       Date:  1976-09-16       Impact factor: 49.962

7.  beta-endorphin is a potent analgesic agent.

Authors:  H H Loh; L F Tseng; E Wei; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1976-08       Impact factor: 11.205

8.  Growth hormone and ACTH secretion: evidence for an inverse relationship in rats.

Authors:  N Kokka; J F Garcia; R George; H W Elliot
Journal:  Endocrinology       Date:  1972-03       Impact factor: 4.736

9.  Radioimmunoassayable growth hormone in the rat pituitary gland: effects of age, sex and hormonal state.

Authors:  C A Birge; G T Peake; I K Mariz; W H Daughaday
Journal:  Endocrinology       Date:  1967-08       Impact factor: 4.736

10.  Inhibition by six somatostatin analogs of plasma growth hormone levels stimulated by thiamylal and morphine in the rat.

Authors:  L Ferland; F Labrie; D H Coy; A Arimura; A V Schally
Journal:  Mol Cell Endocrinol       Date:  1976-01       Impact factor: 4.102

View more
  15 in total

1.  The effects of opiate receptor agonists and antagonists on the stress-induced secretion of corticosterone in mice.

Authors:  A Gibson; M Ginsburg; M Hall; S L Hart
Journal:  Br J Pharmacol       Date:  1979-01       Impact factor: 8.739

Review 2.  Some current aspects of clinical and experimental neuroendocrinology with particular reference to growth hormone, thyrotropin and prolactin.

Authors:  M F Scanlon; M Pourmand; A M McGregor; M D Rodriguez-Arnao; K Hall; A Gomez-Pan; R Hall
Journal:  J Endocrinol Invest       Date:  1979 Jul-Sep       Impact factor: 4.256

3.  Effects of adrenalectomy and hypophysectomy on enkephalin content of the rat hypothalamus.

Authors:  A Gibson; M Ginsburg; S L Hart; I Kitchen
Journal:  Br J Pharmacol       Date:  1980-12       Impact factor: 8.739

4.  Prolactin and growth hormone releasing activity of [D-Met2, Pro5]-enkephalinamide in the rat after systemic administration.

Authors:  V Locatelli; D Cocchi; S Bajusz; S Spampinato; E E Müller
Journal:  Experientia       Date:  1978-12-15

5.  beta-Endorphin: analgesic and hormonal effects in humans.

Authors:  K M Foley; I A Kourides; C E Inturrisi; R F Kaiko; C G Zaroulis; J B Posner; R W Houde; C H Li
Journal:  Proc Natl Acad Sci U S A       Date:  1979-10       Impact factor: 11.205

6.  Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.

Authors:  M Ishibashi; T Yamaji
Journal:  J Clin Invest       Date:  1984-01       Impact factor: 14.808

7.  Regulation of episodic growth hormone secretion by the central epinephrine system. Studies in the chronically cannulated rat.

Authors:  L C Terry; W R Crowley; M D Johnson
Journal:  J Clin Invest       Date:  1982-01       Impact factor: 14.808

8.  Effect of loperamide, a peripheral opiate agonist, on circulating glucose, free fatty acids, insulin, C-peptide and pituitary hormones in healthy man.

Authors:  R Caldara; G P Testori; C Ferrari; M Romussi; P Rampini; M Borzio; C Barbieri
Journal:  Eur J Clin Pharmacol       Date:  1981       Impact factor: 2.953

9.  Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone levels in patients with cancer pain.

Authors:  C F Su; M Y Liu; M T Lin
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

10.  Naloxone does not alter the effect of gamma aminobutyric acid derivative, baclofen, on GH release in man.

Authors:  P Chiodera; R Volpi; V Coiro; L Barilli; G Rossi; E Roti
Journal:  J Endocrinol Invest       Date:  1983-10       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.